National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 2,866 cases where Vaccine targets Shingles (VARZOS) and Hospitalized and Vaccination Date on/before '2019-05-31'

Table

   
AgeCountPercent
< 3 Years20.07%
17-44 Years100.35%
44-65 Years37913.22%
65-75 Years43015%
75+ Years37012.91%
Unknown1,67558.44%
TOTAL2,866100%

Case Details

This is page 1 out of 287

Result pages: 1 2 3 4 5 6 7 8 9 10   next


VAERS ID: 264024 (history)  
Form: Version 1.0  
Age:   
Sex: Male  
Location: New York  
Vaccinated:2006-09-08
Onset:2006-09-09
   Days after vaccination:1
Submitted: 2006-10-02
   Days after onset:23
Entered: 2006-10-05
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Herpes zoster, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES0609USA06560

Write-up: Information has been received from a physician concerning a male pt who on 9/9/06 was vaccianted with a dose of varicella zoster virus vaccine live. On 9/8/06 the pt was hospitalized with a rash. The was diagnosed with a zoster infection. No outcome was reported. No product quality complaint was involved. Additional information has been requested.


VAERS ID: 265040 (history)  
Form: Version 1.0  
Age: 74.0  
Sex: Male  
Location: Missouri  
Vaccinated:2006-10-11
Onset:2006-10-18
   Days after vaccination:7
Submitted: 2006-10-20
   Days after onset:2
Entered: 2006-10-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUVIRIN) / NOVARTIS VACCINES AND DIAGNOSTICS 70089 / 1 RA / IM
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0981F / 1 LA / SC

Administered by: Unknown       Purchased by: Unknown
Symptoms: Anaemia, Dehydration, Hydronephrosis, Prostatic disorder, Pyrexia
SMQs:, Haematopoietic erythropenia (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Meds: metamucil, Ergocalciferol, Flomax, Lidocaine/Prilocaine topical, Hyoscyamine sulfate PRN, vitamins, Vitamin D, and sulfamethoxazole-trimethoprim.
Current Illness: superficial wound infection with B. fragilis.
Preexisting Conditions: allergy-phenergan history of colectomy for ulcerative colitis, osteoporosis, vitamin D deficiency PMH: COPD, Hypertension, Hemorrhoids, Joint pain, Sleep Apnea, cataracts, osteoporosis, diverticuli, low back pain, anemia, sinusitis, allergic rhinitis and testosterone deficiency. Recent surgery for bowel obstruction with wound dehiscence.
Allergies:
Diagnostic Lab Data: CBC no shift, CXR, Urine culture, blood cultures negative. LABS and DIAGNOSTICS: Renal US shows mild left hydronephrosis and moderate postvoid residual.
CDC Split Type:

Write-up: Received Zostavax and flu vaccine on 10/11. Developed fever 102.4 documented on 10/18. Was admitted for IV fluids. No other obvious source found. Had recently been hospitalized and operated for small obstruction which made him susceptible to the dehydration factor. No infectious etiology found related to fever. Hospital and PCP MRs received documenting 73 yr old who presents 1 week s/p Flu and Zostavx immunizations with fever, dysuria, and not feeling well. Patient reports need to push on bladder to empty. Admitted to hospital for hydration and IV antibiotics. Impression: "Suspect UTI from inability to empty bladder well. Doubt reaction to Zostavax" Discharge DX: Fever, Dehydration, Hydronephrosis, BPH with outlet obstruction, concha bullosa, anemia, and past hx. of abd. incision dehiscence.


VAERS ID: 269012 (history)  
Form: Version 1.0  
Age: 71.0  
Sex: Male  
Location: Unknown  
Vaccinated:2006-11-29
Onset:2006-11-29
   Days after vaccination:0
Submitted: 2006-12-12
   Days after onset:13
Entered: 2006-12-18
   Days after submission:6
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / SC

Administered by: Other       Purchased by: Other
Symptoms: Blood glucose increased, Cold sweat, Dehydration, Dizziness, Fatigue, Hypersensitivity, Hypoaesthesia, Lung disorder, Lymphopenia, Nausea, Pallor, Vertigo, Vomiting
SMQs:, Acute pancreatitis (broad), Angioedema (broad), Haematopoietic leukopenia (narrow), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (narrow), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Vestibular disorders (narrow), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Enlarged prostate, sulfonamide allergy.
Allergies:
Diagnostic Lab Data: Chest X ray 11/29/06 hypoexpanded lungs, otherwise within normal limits. Lymphocyte count 11/29/06 14.5, serum glucose 134, serum hemoglobin test 13.8, serum potassium 3.2, hematocrit 41.
CDC Split Type: WAES0612USA00197

Write-up: Information has been received from a investigator concerning a 71 year old male with an enlarged prostate (April 2005) and an allergy to Sulfonamide who entered a study. On 29 Nov 2006, the patient was vaccinated SC in the deltoid with a 0.65 ml dose of varicella Zoster vaccine. Concomitant vaccination on 15 Nov 2006 included a dose of influenza virus vaccine (unspecified). On 29 Nov 2006, prior to vaccination with study therapy, the patient arose early and went exercising without having breakfast. The patient was then screened and vaccainted with Varicella Zoster vaccine. He was observed for 30 minutes and was released feeling well. The patient went home and had breakfast that consisted of eggs and cinnamon bread. Two hours post vaccination, the patient suddenly felt dizzy and nauseated followed by episodes of vomiting. The patient also experienced the sensation of numbness affection his arms, legs and neck. The patient felt clammy and looked pale to his wife who called the study site and spoke with the investigator and his primary care physician. The patient was taken by ambulance to the emergency room on 29 Nov 2006 for nausea, vomiting and vertigo. he was hospitalized for 24 hours in the emergency room and was discharged on 30 Nov 2006. The discharge diagnosis was rule out myocardial infarction with the additional diagnoses of benign paroxym/smal vertigo, dehydration, possible allergic reaction to varicella zoster vaccine. On 01 Dec 2006, the patient was called post release from the emergency department and he felt well. Again, he skipped breakfast and went to exercise. He arrived home to feel lightheaded and fatigues. He took a nap and felt better. On 04 Dec 2006, the patient was called again for an update. He rested over the weekend without further nausea or vomiting. He stated that he felt about 90 percent. Again, he exercised without breakfast and felt lightheaded. He stated the he has continued to have intermittent feelings of dizziness. The patient considered recovered on 30 Nov 2006. The patient''s nausea, vomiting and vertigo was considered to be other important medical events (OMIC). The reporter felt that the patients nausea, vomiting and vertigo was possibly related to vaccination with varicella Zoster vaccine. Additional information has been requested.


VAERS ID: 269643 (history)  
Form: Version 1.0  
Age: 60.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2006-12-01
Onset:2006-12-04
   Days after vaccination:3
Submitted: 2006-12-20
   Days after onset:16
Entered: 2006-12-27
   Days after submission:7
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Abasia, Hypoaesthesia, Pyrexia
SMQs:, Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dystonia (broad), Guillain-Barre syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 11 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory, 12?/??/2006, "blood work," results not reported; body temp, 12?/??/2006, 100 degrees.
CDC Split Type: WAES0612USA02676

Write-up: Information has been received from a physician concerning an "over 60" year old female who in approximately December 2006, was vaccinated with a dose of ZOSTAVAX. Subsequently, 3-4 days after receiving ZOSTAVAX the patient developed numbness in her legs, lips and around her mouth, and a fever. The patient "could not walk" due to this event. The patient was referred to a neurologist to rule out Guillain-Barre Syndrome. The patient was also referred to an infectious disease specialist to determine if the event was vaccine related. At the time of the report the patient''s numbness had improved but she was still spiking a temperature of 100-101 degrees. Unspecified "blood work" was performed. The patient was discharged from the hospital after 11 days as an inpatient. There was no product quality complaint involved. No additional information was available. The reporter considered the patient''s events to be disabling and serious for hospitalization. Additional information has been requested.


VAERS ID: 270076 (history)  
Form: Version 1.0  
Age: 65.0  
Sex: Female  
Location: Unknown  
Vaccinated:2006-12-19
Onset:2006-12-19
   Days after vaccination:0
Submitted: 2007-01-04
   Days after onset:16
Entered: 2007-01-05
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Headache
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES0612USA03416

Write-up: Information has been received from a 65 year old female with no allergies or medical history who on 19-Dec-2006 was vaccinated with a 0.5 ml dose of varicella-zoster virus vaccine live. Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 19-Dec-2006, the patient experienced a headache after vaccination and was hospitalized. The patient recovered on 20-Dec-2006. No diagnostic laboratory test were performed. A product quality complaint was not involved. No further information is available.


VAERS ID: 270421 (history)  
Form: Version 1.0  
Age: 62.0  
Sex: Female  
Location: California  
Vaccinated:2006-12-01
Onset:2007-01-05
   Days after vaccination:35
Submitted: 2007-01-11
   Days after onset:6
Entered: 2007-01-12
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1411F / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Herpes zoster, Infection, Rash, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: (therapy unspecified) (therapy unspecified) (therapy unspecified)
Current Illness:
Preexisting Conditions: MEDICAL HISTORY: Hysterectomy CONCURRENT CONDITIONS: Shingles, Cholesterol, Penicillin allergy, Type II diabetes mellitus, Hypertension
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES0701USA00874

Write-up: Information had been received from a consumer concerning his 62 year old wife with shingles around one of her ears, a penicillin allergy and a history of hysterectomy who was vaccinated in December 2006 with a dose of varicella zoster virus vaccine live. Concomitant therapy included medicine for diabetes, high blood pressure and cholesterol. Approximately twelve days after vaccination, she broke out with rashes and hives all over her body. She was hospitalized on 05 Jan 2007. She was currently still hospitalized. Unspecified laboratory test were performed, the results were not reported. The husband mentioned that approximately one month before his wife was vaccinated she had her first outbreak of shingles in the are around one of her ears. She had almost fully recovered from the shingles at the time she was vaccinated. At the time of the report the patient was not recovered. There was no product quality complaint involved. Additional information has been requested.


VAERS ID: 272432 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2007-02-14
Entered: 2007-02-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. - / UNK UN / -

Administered by: Other       Purchased by: Other
Symptoms: Skin lesion, Varicella
SMQs:, Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0702USA01343

Write-up: Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of ZOSTAVAX. Subsequently the patient developed chickenpox. The number of lesions was not specified. The patient may have possibly been hospitalized after the symptoms appeared. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.


VAERS ID: 273126 (history)  
Form: Version 1.0  
Age: 87.0  
Sex: Female  
Location: Florida  
Vaccinated:2007-02-22
Onset:2007-02-25
   Days after vaccination:3
Submitted: 2007-02-27
   Days after onset:2
Entered: 2007-02-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0033U / 1 LA / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: C-reactive protein increased, Chest pain, White blood cell count increased
SMQs:, Neuroleptic malignant syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: records received 3/20/07-PHX:CAD, pacemaker. Hypertension, macular degeneration status post packemaker,
Allergies:
Diagnostic Lab Data: elevated WBC, elevated CRP Records received 3/20/07-EKG:pacemaker rhythm. Echo doppler:normal left ventricular wall thickness. ejection fraction in excess of 65%. mild mitral regurgitation. small echo free space posteriorly. Labs:leukocytosis 17,000. Labs unremarkable except for C reactive protein 60. Sed rate 16. Cultures negative. CT angio done to exclude pulmonary emboli.
CDC Split Type:

Write-up: chest pain, elevated WBC, pleuritic type chest pain 03/20/07-records received from facility without DC Summary, for DOS 2/26/07-C/O chest pain, pressure sensation intermittent sharp pain to anterior mid chest. Some SOB and radiation of pain down her left arm left shoulder and left hand. Some nause no vomiting no diaphoresis. 04/26/07-per med rec final DX coded was chest pain. DC Summary not dictated.


VAERS ID: 273500 (history)  
Form: Version 1.0  
Age: 70.0  
Sex: Female  
Location: Arizona  
Vaccinated:2007-02-13
Onset:2007-02-16
   Days after vaccination:3
Submitted: 2007-03-06
   Days after onset:18
Entered: 2007-03-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 1476F / 1 LA / SC

Administered by: Unknown       Purchased by: Unknown
Symptoms: Angiogram, Anxiety, Asthenia, Asthma, Chest X-ray, Computerised tomogram, Condition aggravated, Dyspnoea, Electrocardiogram, Hypokalaemia, Hypomagnesaemia, Pulmonary embolism, Troponin, Ultrasound Doppler
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (narrow), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Hypoglycaemia (broad), Hypokalaemia (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Avelox,Ambien,Flexeril,Zoloft/Mucinex/Singulair/Protonix/HydrocodoneAPAP/Albuterol inhaler/
Current Illness: none
Preexisting Conditions: Hypertension, asthma, low back pain records received 3/19/07-PMH:Asthma, hypertension, GERD with periodic endoscopy and dilation and hysterectomy.
Allergies:
Diagnostic Lab Data: Serial troponins, serial ekgs, chest xray, CT angiogram of chest, LE doppler records received 3/19/07-Labs. potassium 2.8, magnesium 1.5 CT angiogram showed small nonoccluding subseqmental pulmonary embolus. Emphysema. Hiatal hernia VQ Scan positive for small subsegmental pulmonary embolus. US duplex of bilateral lower extremities. No evidence of deep vein thrombosis. Per annual follow up, uncertainty regarding correlation between injection and event.
CDC Split Type:

Write-up: Shortness of breath and weakness, leading to ER visit and hospitalization x 3 days- dx was pulmonary embolism, asthma, anxiety, hypokalemia, hypomagnesemia. Unknown if related to vaccine. 03/19/07-records received from facility for DOS 2/16-2/19/07-DC DX:Pulmonary embolism, subsegmental nonocculding. Asthma. Anxiety. Hypokalemia. Hypomagnesemia. C/O shortness of breath times 1 week. Productive green cough and post nasal drip. Dyspnea on exertion but no PND or orthopnea. No chest pain but C/O palpatations. PE:WNL. SOB likely due to underlying asthma exacerbated by viral upper respiratory infection and anxiety. Patients symptoms relieved with lorazepam.


VAERS ID: 273695 (history)  
Form: Version 1.0  
Age: 88.0  
Sex: Male  
Location: Arizona  
Vaccinated:2007-03-05
Onset:2007-03-06
   Days after vaccination:1
Submitted: 2007-03-08
   Days after onset:2
Entered: 2007-03-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PPV: PNEUMO (PNEUMOVAX) / MERCK & CO. INC. 0988F / 2 UN / IM
VARZOS: ZOSTER LIVE (ZOSTAVAX) / MERCK & CO. INC. 0032U / 1 UN / SC

Administered by: Military       Purchased by: Military
Symptoms: Chills, Injection site erythema, Injection site swelling, Injection site warmth, Nausea, Pyrexia
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Records received 3/12/07-PMH: chronic lymphocytic leukemia, skin cancer and neuropathy
Allergies:
Diagnostic Lab Data: Labs received 3/12/07-CXR: right middle lobe pneumonia. Labs: WBC 76.2, UA bacteria which was occult.
CDC Split Type:

Write-up: PT WAS ADMITTED TO HOSPITAL FOR THE FOLLOWING SX''S; FEVER, CHILLS, NAUSEA, SWELLING, REDNESS AND WARMTH AT INJECTION SITE. 03/12/07-records received from facility- Admitted with fevers and cough, decreased appetite and nausea. No shortness of breath.


Result pages: 1 2 3 4 5 6 7 8 9 10   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&VAX[]=VARZOS&VAXTYPES[]=Shingles&HOSPITAL=Yes&VAX_YEAR_HIGH=2019&VAX_MONTH_HIGH=05


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166